BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21720747)

  • 1. Impact of marital status and race on outcomes of patients enrolled in Radiation Therapy Oncology Group prostate cancer trials.
    Du KL; Bae K; Movsas B; Yan Y; Bryan C; Bruner DW
    Support Care Cancer; 2012 Jun; 20(6):1317-25. PubMed ID: 21720747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
    Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
    J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Race and survival of men treated for prostate cancer on radiation therapy oncology group phase III randomized trials.
    Roach M; Lu J; Pilepich MV; Asbell SO; Mohiuddin M; Grignon D
    J Urol; 2003 Jan; 169(1):245-50. PubMed ID: 12478146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trials.
    Hamstra DA; Bae K; Pilepich MV; Hanks GE; Grignon DJ; McGowan DG; Roach M; Lawton C; Lee RJ; Sandler H
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1293-301. PubMed ID: 21458924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group prostate clinical trials.
    Rodrigues G; Bae K; Roach M; Lawton C; Donnelly B; Grignon D; Hanks G; Porter A; Lepor H; Sandler H
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):445-52. PubMed ID: 20615632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.
    Michalski JM; Moughan J; Purdy J; Bosch W; Bruner DW; Bahary JP; Lau H; Duclos M; Parliament M; Morton G; Hamstra D; Seider M; Lock MI; Patel M; Gay H; Vigneault E; Winter K; Sandler H
    JAMA Oncol; 2018 Jun; 4(6):e180039. PubMed ID: 29543933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional Risks of Biochemical Failure and Prostate Cancer-Specific Death in Patients Undergoing External Beam Radiotherapy: A Secondary Analysis of 2 Randomized Clinical Trials.
    Alexander GS; Krc RF; Assif JW; Sun K; Molitoris JK; Tran P; Rana Z; Bentzen SM; Mishra MV
    JAMA Netw Open; 2023 Sep; 6(9):e2335069. PubMed ID: 37751207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Marital Status on the Survival of Patients With Adenocarcinoma of the Esophagogastric Junction: A Population-Based, Propensity-Matched Study.
    Wang S; Chen L; Chen D; Chao J; Shao Y; Tang K; Chen W
    Cancer Control; 2021; 28():10732748211066309. PubMed ID: 34910613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of prostate cancer and bone metastasis pattern of patients: a SEER-based study and a local hospital based study from China.
    Liu D; Kuai Y; Zhu R; Zhou C; Tao Y; Han W; Chen Q
    Sci Rep; 2020 Jun; 10(1):9104. PubMed ID: 32499554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of race on survival in men with metastatic hormone-refractory prostate cancer.
    Halabi S; Small EJ; Vogelzang NJ; Barrier RC; George SL; Gilligan TD
    Urology; 2004 Aug; 64(2):212-7. PubMed ID: 15302462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era.
    Kupelian PA; Buchsbaum JC; Patel C; Elshaikh M; Reddy CA; Zippe C; Klein EA
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):704-11. PubMed ID: 11849793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marital status independently predicts testis cancer survival--an analysis of the SEER database.
    Abern MR; Dude AM; Coogan CL
    Urol Oncol; 2012; 30(4):487-93. PubMed ID: 20870430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 1989 patterns of care study for prostate cancer: five-year outcomes.
    Chuba PJ; Moughan J; Forman JD; Owen J; Hanks G
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):325-34. PubMed ID: 11380218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.
    Fossati N; Karnes RJ; Cozzarini C; Fiorino C; Gandaglia G; Joniau S; Boorjian SA; Goldner G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T; Briganti A
    Eur Urol; 2016 Apr; 69(4):728-733. PubMed ID: 26497924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.
    Ma TM; Romero T; Nickols NG; Rettig MB; Garraway IP; Roach M; Michalski JM; Pisansky TM; Lee WR; Jones CU; Rosenthal SA; Wang C; Hartman H; Nguyen PL; Feng FY; Boutros PC; Saigal C; Chamie K; Jackson WC; Morgan TM; Mehra R; Salami SS; Vince R; Schaeffer EM; Mahal BA; Dess RT; Steinberg ML; Elashoff D; Sandler HM; Spratt DE; Kishan AU
    JAMA Netw Open; 2021 Dec; 4(12):e2139769. PubMed ID: 34964855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of race on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal-access health care system: radiation oncology report of the Department of Defense Center for Prostate Disease Research.
    Johnstone PA; Kane CJ; Sun L; Wu H; Moul JW; McLeod DG; Martin DD; Kusuda L; Lance R; Douglas R; Donahue T; Beat MG; Foley J; Baldwin D; Soderdahl D; Do J; Amling CL
    Radiology; 2002 Nov; 225(2):420-6. PubMed ID: 12409575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08.
    Voog JC; Paulus R; Shipley WU; Smith MR; McGowan DG; Jones CU; Bahary JP; Zeitzer KL; Souhami L; Leibenhaut MH; Rotman M; Husain SM; Gore E; Raben A; Chafe S; Sandler HM; Efstathiou JA
    Eur Urol; 2016 Feb; 69(2):204-10. PubMed ID: 26362090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of marital status, insurance status, income, and race/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States.
    Costa LJ; Brill IK; Brown EE
    Cancer; 2016 Oct; 122(20):3183-3190. PubMed ID: 27548407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do Sociodemographic Factors Influence Outcome in Prostate Cancer Patients Treated With External Beam Radiation Therapy?
    Movsas A; Ibrahim R; Elshaikh MA; Lamerato L; Lu M; Sitarik A; Pradhan D; Walker EM; Stricker H; Freytag SO; Chetty IJ; Movsas B; Siddiqui F
    Am J Clin Oncol; 2016 Dec; 39(6):563-567. PubMed ID: 24879473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single black men have the worst prognosis with localized prostate cancer.
    Liu S; Wang Z; Long X; Fleishman A; Huang X; Wu Q; Gershman B; Olumi AF
    Can J Urol; 2022 Feb; 29(1):10992-11002. PubMed ID: 35150221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.